Finch Therapeutics Group, Inc. (FNCH)

USD 12.74

(-0.08%)

Revenue Summary of Finch Therapeutics Group, Inc.

  • Finch Therapeutics Group, Inc.'s latest annual revenue in 2023 was 107 Thousand USD , down -87.57% from previous year.
  • Finch Therapeutics Group, Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Finch Therapeutics Group, Inc. reported a annual revenue of 861 Thousand USD in annual revenue 2022, down -95.35% from previous year.
  • Finch Therapeutics Group, Inc. reported a annual revenue of 18.53 Million USD in annual revenue 2021, up 140.08% from previous year.
  • Finch Therapeutics Group, Inc. reported a quarterly revenue of - USD for 2024 Q1, down -100.0% from previous quarter.
  • Finch Therapeutics Group, Inc. reported a quarterly revenue of - USD for 2023 Q3, down 0.0% from previous quarter.

Annual Revenue Chart of Finch Therapeutics Group, Inc. (2023 - 2019)

Historical Annual Revenue of Finch Therapeutics Group, Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 107 Thousand USD -87.57%
2022 861 Thousand USD -95.35%
2021 18.53 Million USD 140.08%
2020 7.71 Million USD -23.98%
2019 10.15 Million USD 0.0%

Peer Revenue Comparison of Finch Therapeutics Group, Inc.

Name Revenue Revenue Difference
America Great Health 204.3 Thousand USD 47.628%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -2575.0%
Bio-Path Holdings, Inc. - USD -Infinity%
Better Therapeutics, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 83.099%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. - USD -Infinity%
Galera Therapeutics, Inc. - USD -Infinity%
Innovation1 Biotech Inc. - USD -Infinity%
Kiromic BioPharma, Inc. - USD -Infinity%
Molecular Templates, Inc. 57.3 Million USD 99.813%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD -62.981%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 530 Thousand USD 79.811%
Panbela Therapeutics, Inc. - USD -Infinity%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 99.83%
Statera Biopharma, Inc. - USD -Infinity%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 99.112%
Trevena, Inc. 3.12 Million USD 96.576%
Vaxxinity, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD 81.228%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. 27.65 Thousand USD -286.98%